Pfizer ROE 2006-2018 | PFE

Current and historical return on equity (ROE) values for Pfizer (PFE) over the last 10 years.
Pfizer Annual ROE - Return on Equity
2017 29.81
2016 12.09
2015 10.74
2014 12.74
2013 14.90
2012 11.05
2011 9.52
2010 9.43
2009 9.44
2008 13.96
2007 12.72
2006 15.48
2005 11.60
Pfizer Quarterly ROE - Return on Equity
Q2 2018 5.53
Q1 2018 5.06
Q4 2017 17.15
Q3 2017 4.68
Q2 2017 5.24
Q1 2017 5.33
Q4 2016 1.28
Q3 2016 2.13
Q2 2016 3.27
Q1 2016 4.81
Q4 2015 -0.26
Q3 2015 3.18
Q2 2015 3.92
Q1 2015 3.52
Q4 2014 1.76
Q3 2014 3.42
Q2 2014 3.80
Q1 2014 2.90
Q4 2013 3.44
Q3 2013 3.30
Q2 2013 4.53
Q1 2013 3.16
Q4 2012 1.60
Q3 2012 3.64
Q2 2012 3.75
Q1 2012 2.06
Q4 2011 0.96
Q3 2011 2.57
Q2 2011 2.84
Q1 2011 2.46
Q4 2010 3.39
Q3 2010 0.97
Q2 2010 2.83
Q1 2010 2.24
Q4 2009 0.73
Q3 2009 4.35
Q2 2009 3.58
Q1 2009 4.52
Q4 2008 0.40
Q3 2008 3.36
Q2 2008 4.16
Q1 2008 4.15
Q4 2007 4.24
Q3 2007 1.20
Q2 2007 1.98
Q1 2007 4.65
Q4 2006 2.09
Q3 2006 4.66
Q2 2006 3.35
Q1 2006 5.77
Q4 2005 3.79
Q3 2005 2.22
Q2 2005 5.18
Q1 2005 0.40
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $250.556B $52.546B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $360.770B 17.24
Novartis AG (NVS) Switzerland $192.442B 16.51
Merck (MRK) United States $186.199B 16.44
AbbVie (ABBV) United States $149.625B 14.62
Novo Nordisk (NVO) Denmark $115.970B 18.54
Eli Lilly (LLY) United States $113.359B 20.98
Sanofi (SNY) France $105.440B 13.35
GlaxoSmithKline (GSK) United Kingdom $102.297B 13.66
Bristol-Myers Squibb (BMY) United States $99.527B 18.01
AstraZeneca (AZN) United Kingdom $96.554B 10.62